Considering the advantages, in terms of energetic and anabolic precursors, that a cancer cell can acquire by deregulating the TCA cycle, in this paper, we have assessed whether the modulation of aconitase 2 (ACO2), the second enzyme involved in the TCA cycle, could induce metabolic rearrangements and proliferation defects in cancer cells. The gene discussed is ACO2; the disease is cancer.